Clinical Trials Logo

Cerebral Visual Impairment clinical trials

View clinical trials related to Cerebral Visual Impairment.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05102955 Completed - Cerebral Palsy Clinical Trials

Turkish Validity and Reliability of the Visual Function Classification System (VFCS)

Start date: November 1, 2021
Phase:
Study type: Observational [Patient Registry]

Cerebral Palsy (CP) is the most common childhood disorder that occurs with a lesion in the developing infant brain, seen in 2-3/1000 live births. CP is a posture, movement and tone disorder that occurs due to prenatal or postnatal causes. It is not progressive, but since the anatomy of the lesion and the physical development of the individual are not completed, the course of the disorder may vary throughout life. Accompanied by motor dysfunctions, it varies according to clinical types. In addition to this, various visual, sensory and behavioral problems, speech disorders that cause learning difficulties and cognitive problems can also be observed. Ophthalmic disorders are the most common problem in CP and can also affect the developmental process of the patient. Since ophthalmic disorders and neurological deficits are associated in CP, the relationship between neurological disorder and ophthalmic disorders has been investigated in the literature. The aim of this study is to establish the Turkish validity and reliability of the Visual Function Classification System (VFCS) specific to individuals with Cerebral Palsy (CP).

NCT ID: NCT04051983 Completed - Clinical trials for Cerebral Visual Impairment

iVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment

iVision
Start date: January 2, 2018
Phase:
Study type: Observational [Patient Registry]

The objective of the present study is to develop a therapeutic, adaptive, and enjoyable game that will be used by children with CVI between the mental age of 3 and 12 years. Such a game will be easy to use and implement by the children, their parents, and therapists.